Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) Q4 2025 Earnings Call Transcript March 30, 2026
Operator: Good day, and thank you for standing by. Welcome to the Bicara Therapeutics Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] Please be advised today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Rachel Frank. Please go ahead.
Rachel Frank: Thank you, and good morning, everyone. It’s a pleasure to welcome...
